Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 378 entries
Sorted by: Best Match Show Resources per page
Using Rogers' theory to interpret instructional computer use by COE faculty

faculty

Sahin I, Thompson A.
GSID: nr6Y91VwUFQJ
I Sahin, A Thompson - Journal of Research on Technology in …, 2006 - Taylor & Francis

… faculty development were two major findings from this study. The results from the qualitative data provided information on addressing barriers to faculty … advantage of faculty members' …

Cite
Sahin, I., & Thompson, A. (2006). Using Rogers’ theory to interpret instructional computer use by COE faculty. Journal of Research on Technology in Education, 39(1), 81-104.
Sahin, Ismail, and Ann Thompson. "Using Rogers’ theory to interpret instructional computer use by COE faculty." Journal of Research on Technology in Education 39.1 (2006): 81-104.
Copy Download .nbib Format: MLA
[The current status and future prospect of the 2-year-nursing course].

[Kango kyoiku] Japanese journal of nurses' education

Iribe H, Asohina S, Maeda K, Goto K, Yamomoto F, Yamashita K, Nobuchika H.
PMID: 6902791
Kango Kyoiku. 1980 Aug;21(8):489-500.

No abstract available.

Cite
Iribe H, Asohina S, Maeda K, et al. [The current status and future prospect of the 2-year-nursing course]. Kango Kyoiku. 1980;21(8):489-500
Iribe, H., Asohina, S., Maeda, K., Goto, K., Yamomoto, F., Yamashita, K., & Nobuchika, H. (1980). [The current status and future prospect of the 2-year-nursing course]. [Kango kyoiku] Japanese journal of nurses' education, 21(8), 489-500.
Iribe, H, et al. "[The current status and future prospect of the 2-year-nursing course]." [Kango kyoiku] Japanese journal of nurses' education vol. 21,8 (1980): 489-500.
Iribe H, Asohina S, Maeda K, Goto K, Yamomoto F, Yamashita K, Nobuchika H. [The current status and future prospect of the 2-year-nursing course]. Kango Kyoiku. 1980 Aug;21(8):489-500. Japanese. PMID: 6902791.
Copy Download .nbib Format: NLM
Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study.

Patient preference and adherence

Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N.
PMID: 27274207
Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016.

OBJECTIVE: The objective of this study is to evaluate the impact of sequential telephonic interviews on treatment persistence and daily adherence to insulin injections among insulin-naïve type 2 diabetes patients initiated on different insulin regimens in a 3-month period.METHODS:...

Cite
Yavuz DG, Bilen H, Sancak S, et al. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016;10:851-61doi: 10.2147/PPA.S100626.
Yavuz, D. G., Bilen, H., Sancak, S., Garip, T., Hekimsoy, Z., Sahin, I., Yilmaz, M., Aydin, H., Atmaca, A., Sert, M., Karakaya, P., Arpaci, D., Oguz, A., & Guvener, N. (2016). Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient preference and adherence, 10851-61. https://doi.org/10.2147/PPA.S100626
Yavuz, Dilek Gogas, et al. "Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study." Patient preference and adherence vol. 10 (2016): 851-61. doi: https://doi.org/10.2147/PPA.S100626
Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016. PMID: 27274207; PMCID: PMC4876103.
Copy Download .nbib Format: NLM
Identification of a Histidine Metal Ligand in the argE-Encoded N-Acetyl-L-Ornithine Deacetylase from Escherichia coli.

SpringerPlus

McGregor WC, Gillner DM, Swierczek SI, Liu D, Holz RC.
PMID: 25674394
Springerplus. 2013 Sep 23;2:482. doi: 10.1186/2193-1801-2-482. eCollection 2013.

The H355A, H355K, H80A, and H80K mutant enzymes of the argE-encoded N-acetyl-L-ornithine deacetylase (ArgE) from Escherichia coli were prepared, however, only the H355A enzyme was found to be soluble. Kinetic analysis of the Co(II)-loaded H355A exhibited activity levels that...

Cite
McGregor WC, Gillner DM, Swierczek SI, et al. Identification of a Histidine Metal Ligand in the argE-Encoded N-Acetyl-L-Ornithine Deacetylase from Escherichia coli. Springerplus. 2013;2:482doi: 10.1186/2193-1801-2-482.
McGregor, W. C., Gillner, D. M., Swierczek, S. I., Liu, D., & Holz, R. C. (2013). Identification of a Histidine Metal Ligand in the argE-Encoded N-Acetyl-L-Ornithine Deacetylase from Escherichia coli. SpringerPlus, 2482. https://doi.org/10.1186/2193-1801-2-482
McGregor, Wade C, et al. "Identification of a Histidine Metal Ligand in the argE-Encoded N-Acetyl-L-Ornithine Deacetylase from Escherichia coli." SpringerPlus vol. 2 (2013): 482. doi: https://doi.org/10.1186/2193-1801-2-482
McGregor WC, Gillner DM, Swierczek SI, Liu D, Holz RC. Identification of a Histidine Metal Ligand in the argE-Encoded N-Acetyl-L-Ornithine Deacetylase from Escherichia coli. Springerplus. 2013 Sep 23;2:482. doi: 10.1186/2193-1801-2-482. eCollection 2013. PMID: 25674394; PMCID: PMC4320195.
Copy Download .nbib Format: NLM
Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation.

BioResearch open access

Umebayashi M, Sumita Y, Kawai Y, Watanabe S, Asahina I.
PMID: 26309793
Biores Open Access. 2015 Feb 01;4(1):164-74. doi: 10.1089/biores.2014.0057. eCollection 2015.

To date, therapeutic method for in vivo gene delivery has not been established on bone engineering though its potential usefulness has been suggested. For clinical applications, an effective condition should be developed to transfer the genes in vivo without...

Cite
Umebayashi M, Sumita Y, Kawai Y, et al. Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation. Biores Open Access. 2015;4(1):164-74doi: 10.1089/biores.2014.0057.
Umebayashi, M., Sumita, Y., Kawai, Y., Watanabe, S., & Asahina, I. (2015). Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation. BioResearch open access, 4(1), 164-74. https://doi.org/10.1089/biores.2014.0057
Umebayashi, Mayumi, et al. "Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation." BioResearch open access vol. 4,1 (2015): 164-74. doi: https://doi.org/10.1089/biores.2014.0057
Umebayashi M, Sumita Y, Kawai Y, Watanabe S, Asahina I. Gene-Activated Matrix Comprised of Atelocollagen and Plasmid DNA Encoding BMP4 or Runx2 Promotes Rat Cranial Bone Augmentation. Biores Open Access. 2015 Feb 01;4(1):164-74. doi: 10.1089/biores.2014.0057. eCollection 2015. PMID: 26309793; PMCID: PMC4497668.
Copy Download .nbib Format: NLM
Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells.

Hepatology research : the official journal of the Japan Society of Hepatology

Goto F, Kakinuma S, Miyoshi M, Tsunoda T, Kaneko S, Sato A, Asano Y, Otani S, Azuma S, Nagata H, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Nakagawa M, Asahina Y, Watanabe M.
PMID: 27670640
Hepatol Res. 2017 Aug;47(9):941-952. doi: 10.1111/hepr.12823. Epub 2016 Oct 31.

Fetal hepatic stem/progenitor cells, called hepatoblasts, play central roles in liver organogenesis; however, molecular mechanisms regulating proliferation and terminal differentiation of such cells have not been completely elucidated. Bone morphogenetic protein-4 (BMP-4) is essential for the development of stem...

Cite
Goto F, Kakinuma S, Miyoshi M, et al. Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol Res. 2016;47(9):941-952doi: 10.1111/hepr.12823.
Goto, F., Kakinuma, S., Miyoshi, M., Tsunoda, T., Kaneko, S., Sato, A., Asano, Y., Otani, S., Azuma, S., Nagata, H., Kawai-Kitahata, F., Murakawa, M., Nitta, S., Itsui, Y., Nakagawa, M., Asahina, Y., & Watanabe, M. (2017). Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatology research : the official journal of the Japan Society of Hepatology, 47(9), 941-952. https://doi.org/10.1111/hepr.12823
Goto, Fumio, et al. "Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,9 (2017): 941-952. doi: https://doi.org/10.1111/hepr.12823
Goto F, Kakinuma S, Miyoshi M, Tsunoda T, Kaneko S, Sato A, Asano Y, Otani S, Azuma S, Nagata H, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Nakagawa M, Asahina Y, Watanabe M. Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol Res. 2017 Aug;47(9):941-952. doi: 10.1111/hepr.12823. Epub 2016 Oct 31. PMID: 27670640.
Copy Download .nbib Format: NLM
Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Scientific reports

Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T.
PMID: 26670698
Sci Rep. 2015 Dec 16;5:17208. doi: 10.1038/srep17208.

No abstract available.

Cite
Tasaka-Fujita M, Sugiyama N, Kang W, et al. Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression. Sci Rep. 2015;5:17208doi: 10.1038/srep17208.
Tasaka-Fujita, M., Sugiyama, N., Kang, W., Masaki, T., Murayama, A., Yamada, N., Sugiyama, R., Tsukuda, S., Watashi, K., Asahina, Y., Sakamoto, N., Wakita, T., Shin, E. C., & Kato, T. (2015). Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression. Scientific reports, 517208. https://doi.org/10.1038/srep17208
Tasaka-Fujita, Megumi, et al. "Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression." Scientific reports vol. 5 (2015): 17208. doi: https://doi.org/10.1038/srep17208
Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T. Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression. Sci Rep. 2015 Dec 16;5:17208. doi: 10.1038/srep17208. PMID: 26670698; PMCID: PMC4681186.
Copy Download .nbib Format: NLM
Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity.

Advances in pharmacological sciences

Soria EA, Quiroga PL, Albrecht C, Ramos Elizagaray SI, Cantero JJ, Bongiovanni GA.
PMID: 25002868
Adv Pharmacol Sci. 2014;2014:416761. doi: 10.1155/2014/416761. Epub 2014 Jun 05.

Phytochemicals have been presumed to possess prophylactic and curative properties in several pathologies, such as arsenic- (As-) induced immunosuppression. Our aim was to discover a lymphoprotective extract from Lantana grisebachii Stuck. (Verbenaceae) (LG). We assessed its bioactivity and chemical...

Cite
Soria EA, Quiroga PL, Albrecht C, et al. Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity. Adv Pharmacol Sci. 2014;2014:416761doi: 10.1155/2014/416761.
Soria, E. A., Quiroga, P. L., Albrecht, C., Ramos Elizagaray, S. I., Cantero, J. J., & Bongiovanni, G. A. (2014). Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity. Advances in pharmacological sciences, 2014416761. https://doi.org/10.1155/2014/416761
Soria, Elio A, et al. "Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity." Advances in pharmacological sciences vol. 2014 (2014): 416761. doi: https://doi.org/10.1155/2014/416761
Soria EA, Quiroga PL, Albrecht C, Ramos Elizagaray SI, Cantero JJ, Bongiovanni GA. Development of an Antioxidant Phytoextract of Lantana grisebachii with Lymphoprotective Activity against In Vitro Arsenic Toxicity. Adv Pharmacol Sci. 2014;2014:416761. doi: 10.1155/2014/416761. Epub 2014 Jun 05. PMID: 25002868; PMCID: PMC4070537.
Copy Download .nbib Format: NLM
Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence.

Oncology letters

Naruse T, Yamashita K, Yanamoto S, Rokutanda S, Matsushita Y, Sakamoto Y, Sakamoto H, Ikeda H, Ikeda T, Asahina I, Umeda M.
PMID: 28521454
Oncol Lett. 2017 May;13(5):3487-3493. doi: 10.3892/ol.2017.5905. Epub 2017 Mar 24.

The aim of the present study was to identify the most useful markers for predicting recurrence of keratocystic odontogenic tumors (KCOTs). A total of 65 tumor samples from 63 patients diagnosed with typical parakeratinized cysts and KCOTs between 1992...

Cite
Naruse T, Yamashita K, Yanamoto S, et al. Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence. Oncol Lett. 2017;13(5):3487-3493doi: 10.3892/ol.2017.5905.
Naruse, T., Yamashita, K., Yanamoto, S., Rokutanda, S., Matsushita, Y., Sakamoto, Y., Sakamoto, H., Ikeda, H., Ikeda, T., Asahina, I., & Umeda, M. (2017). Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence. Oncology letters, 13(5), 3487-3493. https://doi.org/10.3892/ol.2017.5905
Naruse, Tomofumi, et al. "Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence." Oncology letters vol. 13,5 (2017): 3487-3493. doi: https://doi.org/10.3892/ol.2017.5905
Naruse T, Yamashita K, Yanamoto S, Rokutanda S, Matsushita Y, Sakamoto Y, Sakamoto H, Ikeda H, Ikeda T, Asahina I, Umeda M. Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence. Oncol Lett. 2017 May;13(5):3487-3493. doi: 10.3892/ol.2017.5905. Epub 2017 Mar 24. PMID: 28521454; PMCID: PMC5431266.
Copy Download .nbib Format: NLM
Effects of Batatasin III and Its Analogs on Gibberellic Acid-Dependent α-Amylase Induction in Embryoless Barley Seeds and on Cress Growth.

Bioscience, biotechnology, and biochemistry

Asahina H, Yoshikawa H, Shuto Y.
PMID: 27388847
Biosci Biotechnol Biochem. 1998;62(8):1619-20. doi: 10.1271/bbb.62.1619.

The effects of batatasin III and its analogs on gibberellic acid (GA3)-dependent α-amylase induction in embryoless barley seeds and on cress root-growth were examined. Batatasin III was most effective and caused 68% inhibition of α-amylase induction at 4×10(-4) M,...

Cite
Asahina H, Yoshikawa H, Shuto Y. Effects of Batatasin III and Its Analogs on Gibberellic Acid-Dependent α-Amylase Induction in Embryoless Barley Seeds and on Cress Growth. Biosci Biotechnol Biochem. 1998;62(8):1619-20doi: 10.1271/bbb.62.1619.
Asahina, H., Yoshikawa, H., & Shuto, Y. (1998). Effects of Batatasin III and Its Analogs on Gibberellic Acid-Dependent α-Amylase Induction in Embryoless Barley Seeds and on Cress Growth. Bioscience, biotechnology, and biochemistry, 62(8), 1619-20. https://doi.org/10.1271/bbb.62.1619
Asahina, H, et al. "Effects of Batatasin III and Its Analogs on Gibberellic Acid-Dependent α-Amylase Induction in Embryoless Barley Seeds and on Cress Growth." Bioscience, biotechnology, and biochemistry vol. 62,8 (1998): 1619-20. doi: https://doi.org/10.1271/bbb.62.1619
Asahina H, Yoshikawa H, Shuto Y. Effects of Batatasin III and Its Analogs on Gibberellic Acid-Dependent α-Amylase Induction in Embryoless Barley Seeds and on Cress Growth. Biosci Biotechnol Biochem. 1998;62(8):1619-20. doi: 10.1271/bbb.62.1619. PMID: 27388847.
Copy Download .nbib Format: NLM
Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis.

Molecular and clinical oncology

Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, Shiraishi T, Yamada SI, Asahina I, Umeda M.
PMID: 27446558
Mol Clin Oncol. 2016 Aug;5(2):246-252. doi: 10.3892/mco.2016.928. Epub 2016 Jun 13.

The aim of this retrospective study was to assess the efficacy and safety of cetuximab therapy for patients with locally advanced (LA) and recurrent/metastatic (R/M) oral squamous cell carcinoma (OSCC), with a specific focus on distant metastases (DMs). Data...

Cite
Naruse T, Yanamoto S, Matsushita Y, et al. Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis. Mol Clin Oncol. 2016;5(2):246-252doi: 10.3892/mco.2016.928.
Naruse, T., Yanamoto, S., Matsushita, Y., Sakamoto, Y., Morishita, K., Ohba, S., Shiraishi, T., Yamada, S. I., Asahina, I., & Umeda, M. (2016). Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis. Molecular and clinical oncology, 5(2), 246-252. https://doi.org/10.3892/mco.2016.928
Naruse, Tomofumi, et al. "Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis." Molecular and clinical oncology vol. 5,2 (2016): 246-252. doi: https://doi.org/10.3892/mco.2016.928
Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, Shiraishi T, Yamada SI, Asahina I, Umeda M. Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis. Mol Clin Oncol. 2016 Aug;5(2):246-252. doi: 10.3892/mco.2016.928. Epub 2016 Jun 13. PMID: 27446558; PMCID: PMC4950138.
Copy Download .nbib Format: NLM
A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis.

Journal of central nervous system disease

Satoh J, Asahina N, Kitano S, Kino Y.
PMID: 26023283
J Cent Nerv Syst Dis. 2015 May 18;7:1-14. doi: 10.4137/JCNSD.S23210. eCollection 2015.

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is an intractable neurodegenerative disease that primarily affects motor neurons in the cerebral cortex and the spinal cord. Recent evidence indicates that dysfunction of oligodendrocytes is implicated in the pathogenesis of ALS. The basic...

Cite
Satoh J, Asahina N, Kitano S, et al. A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. J Cent Nerv Syst Dis. 2015;7:1-14doi: 10.4137/JCNSD.S23210.
Satoh, J., Asahina, N., Kitano, S., & Kino, Y. (2015). A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. Journal of central nervous system disease, 71-14. https://doi.org/10.4137/JCNSD.S23210
Satoh, Jun-Ichi, et al. "A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis." Journal of central nervous system disease vol. 7 (2015): 1-14. doi: https://doi.org/10.4137/JCNSD.S23210
Satoh J, Asahina N, Kitano S, Kino Y. A Comprehensive Profile of ChIP-Seq-Based Olig2 Target Genes in Motor Neuron Progenitor Cells Suggests the Possible Involvement of Olig2 in the Pathogenesis of Amyotrophic Lateral Sclerosis. J Cent Nerv Syst Dis. 2015 May 18;7:1-14. doi: 10.4137/JCNSD.S23210. eCollection 2015. PMID: 26023283; PMCID: PMC4437538.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 378 entries